While these concerns are valid, microdosing outside of clinical guidance is not a safe or evidence-based workaround
The outer part of your thigh, about halfway between your hip and knee, is recommended
These particles indicate that the solution is no longer stable or has been contaminated
11 12 GLP-1s lower blood sugar, blood pressure, body weight, and inflammationall of which reduce strain on the heart and blood vessels 13 GLP-1 receptors are found in the heart and arteries, where they may also improve endothelial function, increase nitric oxide, and reduce oxidative stress, helping stabilize plaque and improve how the heart uses energy, especially during stress
When we stratified patients by history of renal disease, the use of the GLP-1 receptor agonist-SGLT-2 inhibitor combination in patients with a history of renal disease was associated with a lower hazard ratio for major adverse cardiovascular events (0.41, 0.18 to 0.94) compared with patients without previous renal disease (0.80, 0.57 to 1.12
